Breast Cancer Liquid Biopsy Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: B452D5E3DC93EN
Market Monitor Global

Abstracts

Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.

This report contains market size and forecasts of Breast Cancer Liquid Biopsy in Global, including the following market information:

Global Breast Cancer Liquid Biopsy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Breast Cancer Liquid Biopsy market was valued at 330.1 million in 2021 and is projected to reach US$ 971.4 million by 2028, at a CAGR of 16.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Circulating Tumor Cells (CTCs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Breast Cancer Liquid Biopsy include QIAGEN, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini Silicon Biosystems, Genomic Health, Thermo Fisher Scientific, Illumina and Biocept, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Breast Cancer Liquid Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Breast Cancer Liquid Biopsy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Breast Cancer Liquid Biopsy Market Segment Percentages, by Type, 2021 (%)

• Circulating Tumor Cells (CTCs)
• Cell-Free DNA (CfDNA)
• Extracellular Vesicles (EVs)
• Other Circulating Biomarkers

Global Breast Cancer Liquid Biopsy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Breast Cancer Liquid Biopsy Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostic Centers
• Laboratories

Global Breast Cancer Liquid Biopsy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Breast Cancer Liquid Biopsy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Breast Cancer Liquid Biopsy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Breast Cancer Liquid Biopsy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• QIAGEN
• Roche Diagnostics
• Bio-Rad Laboratories
• Myriad Genetics
• Menarini Silicon Biosystems
• Genomic Health
• Thermo Fisher Scientific
• Illumina
• Biocept
• Trovagene
• Guardant Health
• RainDance Technologies
• MDx Health

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Breast Cancer Liquid Biopsy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Breast Cancer Liquid Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BREAST CANCER LIQUID BIOPSY OVERALL MARKET SIZE

2.1 Global Breast Cancer Liquid Biopsy Market Size: 2021 VS 2028
2.2 Global Breast Cancer Liquid Biopsy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Breast Cancer Liquid Biopsy Players in Global Market
3.2 Top Global Breast Cancer Liquid Biopsy Companies Ranked by Revenue
3.3 Global Breast Cancer Liquid Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Liquid Biopsy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Breast Cancer Liquid Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Liquid Biopsy Players in Global Market
  3.6.1 List of Global Tier 1 Breast Cancer Liquid Biopsy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Liquid Biopsy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Breast Cancer Liquid Biopsy Market Size Markets, 2021 & 2028
  4.1.2 Circulating Tumor Cells (CTCs)
  4.1.3 Cell-Free DNA (CfDNA)
  4.1.4 Extracellular Vesicles (EVs)
  4.1.5 Other Circulating Biomarkers
4.2 By Type - Global Breast Cancer Liquid Biopsy Revenue & Forecasts
  4.2.1 By Type - Global Breast Cancer Liquid Biopsy Revenue, 2017-2022
  4.2.2 By Type - Global Breast Cancer Liquid Biopsy Revenue, 2023-2028
  4.2.3 By Type - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Breast Cancer Liquid Biopsy Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostic Centers
  5.1.4 Laboratories
5.2 By Application - Global Breast Cancer Liquid Biopsy Revenue & Forecasts
  5.2.1 By Application - Global Breast Cancer Liquid Biopsy Revenue, 2017-2022
  5.2.2 By Application - Global Breast Cancer Liquid Biopsy Revenue, 2023-2028
  5.2.3 By Application - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Breast Cancer Liquid Biopsy Market Size, 2021 & 2028
6.2 By Region - Global Breast Cancer Liquid Biopsy Revenue & Forecasts
  6.2.1 By Region - Global Breast Cancer Liquid Biopsy Revenue, 2017-2022
  6.2.2 By Region - Global Breast Cancer Liquid Biopsy Revenue, 2023-2028
  6.2.3 By Region - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Breast Cancer Liquid Biopsy Revenue, 2017-2028
  6.3.2 US Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.3.3 Canada Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.3.4 Mexico Breast Cancer Liquid Biopsy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Breast Cancer Liquid Biopsy Revenue, 2017-2028
  6.4.2 Germany Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.4.3 France Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.4.4 U.K. Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.4.5 Italy Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.4.6 Russia Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.4.7 Nordic Countries Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.4.8 Benelux Breast Cancer Liquid Biopsy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Breast Cancer Liquid Biopsy Revenue, 2017-2028
  6.5.2 China Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.5.3 Japan Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.5.4 South Korea Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.5.5 Southeast Asia Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.5.6 India Breast Cancer Liquid Biopsy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Breast Cancer Liquid Biopsy Revenue, 2017-2028
  6.6.2 Brazil Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.6.3 Argentina Breast Cancer Liquid Biopsy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Breast Cancer Liquid Biopsy Revenue, 2017-2028
  6.7.2 Turkey Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.7.3 Israel Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.7.4 Saudi Arabia Breast Cancer Liquid Biopsy Market Size, 2017-2028
  6.7.5 UAE Breast Cancer Liquid Biopsy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 QIAGEN
  7.1.1 QIAGEN Corporate Summary
  7.1.2 QIAGEN Business Overview
  7.1.3 QIAGEN Breast Cancer Liquid Biopsy Major Product Offerings
  7.1.4 QIAGEN Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.1.5 QIAGEN Key News
7.2 Roche Diagnostics
  7.2.1 Roche Diagnostics Corporate Summary
  7.2.2 Roche Diagnostics Business Overview
  7.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Major Product Offerings
  7.2.4 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.2.5 Roche Diagnostics Key News
7.3 Bio-Rad Laboratories
  7.3.1 Bio-Rad Laboratories Corporate Summary
  7.3.2 Bio-Rad Laboratories Business Overview
  7.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Major Product Offerings
  7.3.4 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.3.5 Bio-Rad Laboratories Key News
7.4 Myriad Genetics
  7.4.1 Myriad Genetics Corporate Summary
  7.4.2 Myriad Genetics Business Overview
  7.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Major Product Offerings
  7.4.4 Myriad Genetics Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.4.5 Myriad Genetics Key News
7.5 Menarini Silicon Biosystems
  7.5.1 Menarini Silicon Biosystems Corporate Summary
  7.5.2 Menarini Silicon Biosystems Business Overview
  7.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Major Product Offerings
  7.5.4 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.5.5 Menarini Silicon Biosystems Key News
7.6 Genomic Health
  7.6.1 Genomic Health Corporate Summary
  7.6.2 Genomic Health Business Overview
  7.6.3 Genomic Health Breast Cancer Liquid Biopsy Major Product Offerings
  7.6.4 Genomic Health Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.6.5 Genomic Health Key News
7.7 Thermo Fisher Scientific
  7.7.1 Thermo Fisher Scientific Corporate Summary
  7.7.2 Thermo Fisher Scientific Business Overview
  7.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Major Product Offerings
  7.7.4 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.7.5 Thermo Fisher Scientific Key News
7.8 Illumina
  7.8.1 Illumina Corporate Summary
  7.8.2 Illumina Business Overview
  7.8.3 Illumina Breast Cancer Liquid Biopsy Major Product Offerings
  7.8.4 Illumina Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.8.5 Illumina Key News
7.9 Biocept
  7.9.1 Biocept Corporate Summary
  7.9.2 Biocept Business Overview
  7.9.3 Biocept Breast Cancer Liquid Biopsy Major Product Offerings
  7.9.4 Biocept Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.9.5 Biocept Key News
7.10 Trovagene
  7.10.1 Trovagene Corporate Summary
  7.10.2 Trovagene Business Overview
  7.10.3 Trovagene Breast Cancer Liquid Biopsy Major Product Offerings
  7.10.4 Trovagene Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.10.5 Trovagene Key News
7.11 Guardant Health
  7.11.1 Guardant Health Corporate Summary
  7.11.2 Guardant Health Business Overview
  7.11.3 Guardant Health Breast Cancer Liquid Biopsy Major Product Offerings
  7.11.4 Guardant Health Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.11.5 Guardant Health Key News
7.12 RainDance Technologies
  7.12.1 RainDance Technologies Corporate Summary
  7.12.2 RainDance Technologies Business Overview
  7.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Major Product Offerings
  7.12.4 RainDance Technologies Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.12.5 RainDance Technologies Key News
7.13 MDx Health
  7.13.1 MDx Health Corporate Summary
  7.13.2 MDx Health Business Overview
  7.13.3 MDx Health Breast Cancer Liquid Biopsy Major Product Offerings
  7.13.4 MDx Health Breast Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
  7.13.5 MDx Health Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Breast Cancer Liquid Biopsy Market Opportunities & Trends in Global Market
Table 2. Breast Cancer Liquid Biopsy Market Drivers in Global Market
Table 3. Breast Cancer Liquid Biopsy Market Restraints in Global Market
Table 4. Key Players of Breast Cancer Liquid Biopsy in Global Market
Table 5. Top Breast Cancer Liquid Biopsy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Breast Cancer Liquid Biopsy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Breast Cancer Liquid Biopsy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Breast Cancer Liquid Biopsy Product Type
Table 9. List of Global Tier 1 Breast Cancer Liquid Biopsy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Liquid Biopsy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Breast Cancer Liquid Biopsy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Breast Cancer Liquid Biopsy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Breast Cancer Liquid Biopsy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Breast Cancer Liquid Biopsy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Breast Cancer Liquid Biopsy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Breast Cancer Liquid Biopsy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 30. QIAGEN Corporate Summary
Table 31. QIAGEN Breast Cancer Liquid Biopsy Product Offerings
Table 32. QIAGEN Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 33. Roche Diagnostics Corporate Summary
Table 34. Roche Diagnostics Breast Cancer Liquid Biopsy Product Offerings
Table 35. Roche Diagnostics Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 36. Bio-Rad Laboratories Corporate Summary
Table 37. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Offerings
Table 38. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 39. Myriad Genetics Corporate Summary
Table 40. Myriad Genetics Breast Cancer Liquid Biopsy Product Offerings
Table 41. Myriad Genetics Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 42. Menarini Silicon Biosystems Corporate Summary
Table 43. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Offerings
Table 44. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 45. Genomic Health Corporate Summary
Table 46. Genomic Health Breast Cancer Liquid Biopsy Product Offerings
Table 47. Genomic Health Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 48. Thermo Fisher Scientific Corporate Summary
Table 49. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Offerings
Table 50. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 51. Illumina Corporate Summary
Table 52. Illumina Breast Cancer Liquid Biopsy Product Offerings
Table 53. Illumina Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 54. Biocept Corporate Summary
Table 55. Biocept Breast Cancer Liquid Biopsy Product Offerings
Table 56. Biocept Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 57. Trovagene Corporate Summary
Table 58. Trovagene Breast Cancer Liquid Biopsy Product Offerings
Table 59. Trovagene Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 60. Guardant Health Corporate Summary
Table 61. Guardant Health Breast Cancer Liquid Biopsy Product Offerings
Table 62. Guardant Health Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 63. RainDance Technologies Corporate Summary
Table 64. RainDance Technologies Breast Cancer Liquid Biopsy Product Offerings
Table 65. RainDance Technologies Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 66. MDx Health Corporate Summary
Table 67. MDx Health Breast Cancer Liquid Biopsy Product Offerings
Table 68. MDx Health Breast Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Breast Cancer Liquid Biopsy Segment by Type in 2021
Figure 2. Breast Cancer Liquid Biopsy Segment by Application in 2021
Figure 3. Global Breast Cancer Liquid Biopsy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Breast Cancer Liquid Biopsy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Breast Cancer Liquid Biopsy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Breast Cancer Liquid Biopsy Revenue in 2021
Figure 8. By Type - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 12. US Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 16. Germany Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 17. France Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 24. China Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 28. India Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 30. Brazil Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Breast Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 33. Turkey Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Breast Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 37. QIAGEN Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Diagnostics Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Myriad Genetics Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Genomic Health Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Illumina Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biocept Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Trovagene Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Guardant Health Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. RainDance Technologies Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. MDx Health Breast Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)